Gene · 3799
Papers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,390
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation. | J Hematol Oncol | 2022 | 35690785 | PubTator, text mining | PubMed |
| ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | Nucleic Acids Res | 2022 | 35687106 | PubTator, text mining | PubMed |
| CRISPR-Cas technology a new era in genomic engineering. | Biotechnol Rep (Amst) | 2022 | 35686011 | PubTator, text mining | PubMed |
| Identification of an Autophagy-Related Signature Based on Whole Bone Marrow Sequencing for the Prognosis and Immune Microenvironment Characterization of Multiple Myeloma. | J Immunol Res | 2022 | 35677537 | PubTator, text mining | PubMed |
| Case Report: Rare Systemic and Aggressive ALK-Positive Histiocytosis With Recurrent Pancreatitis Treating by Alectinib. | Front Med (Lausanne) | 2022 | 35665359 | PubTator, text mining | PubMed |
| LMO7-ALK Fusion in a Lung Adenocarcinoma Patient With Crizotinib: A Case Report. | Front Oncol | 2022 | 35664754 | PubTator, text mining | PubMed |
| Semen Ziziphi Spinosae attenuates blood-brain barrier dysfunction induced by lipopolysaccharide by targeting the FAK-DOCK180-Rac1-WAVE2-Arp3 signaling pathway. | NPJ Sci Food | 2022 | 35655066 | PubTator, text mining | PubMed |
| BORC-ARL8-HOPS ensemble is required for lysosomal cholesterol egress through NPC2. | Mol Biol Cell | 2022 | 35653304 | PubTator, text mining | PubMed |
| Synergistic autoinhibition and activation mechanisms control kinesin-1 motor activity. | Cell Rep | 2022 | 35649356 | PubTator, text mining | PubMed |
| Identification of Two Exosomal miRNAs in Circulating Blood of Cancer Patients by Using Integrative Transcriptome and Network Analysis. | Noncoding RNA | 2022 | 35645340 | PubTator, text mining | PubMed |
| GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells. | Cancers (Basel) | 2022 | 35626166 | PubTator, text mining | PubMed |
| Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients. | Cancers (Basel) | 2022 | 35625958 | PubTator, text mining | PubMed |
| Endocytic trafficking of GAS6-AXL complexes is associated with sustained AKT activation. | Cell Mol Life Sci | 2022 | 35622156 | PubTator, text mining | PubMed |
| The significance of the fusion partner gene genomic neighborhood analysis in translocation-defined tumors. | Mol Genet Genomic Med | 2022 | 35621010 | PubTator, text mining | PubMed |
| Alectinib versus crizotinib in ALK-positive advanced non-small cell lung cancer and comparison of next-generation TKIs after crizotinib failure: Real-world evidence. | Cancer Med | 2022 | 35616090 | PubTator, text mining | PubMed |
| Failure of crizotinib based systemic treatment in ALK positive histiocytosis involving the central nervous system: a case report and literature review. | BMC Pediatr | 2022 | 35614430 | PubTator, text mining | PubMed |
| The HERITAGE Family Study: A Review of the Effects of Exercise Training on Cardiometabolic Health, with Insights into Molecular Transducers. | Med Sci Sports Exerc | 2022 | 35611651 | PubTator, text mining | PubMed |
| Mechanisms of Mitochondrial Malfunction in Alzheimer's Disease: New Therapeutic Hope. | Oxid Med Cell Longev | 2022 | 35607703 | PubTator, text mining | PubMed |
| Brucella activates the host RIDD pathway to subvert BLOS1-directed immune defense. | Elife | 2022 | 35587649 | PubTator, text mining | PubMed |
| New horizons for uncommon mutations in non-small cell lung cancer: BRAF, KRAS, RET, MET, NTRK, HER2. | World J Clin Oncol | 2022 | 35582653 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3799/papers?page=29